Joanne Yun, based in San Francisco and Palo Alto, is a core member of Egon Zehnder’s global Health Practice. In addition to her commercial and Board work for global pharmaceutical and biotechnology companies, Joanne leads the Research & Development segment of the Health Practice. She has a particular interest in the transition of academic leaders into industry, and is active in the academia and not-for-profit segments of the firm’s Public and Social Sector Practice. Joanne is Egon Zehnder’s office leader in San Francisco.More
Prior to joining Egon Zehnder, Joanne served as a director in the Global Oncology Business Unit for Bayer HealthCare Pharmaceuticals with responsibility for oncology program management and new product planning. She advised on all aspects of research, development, and commercial strategy, including portfolio prioritization, business development, alliance governance, and merger integration. Joanne started her career with Bayer AG as a bench chemist and Laboratory Head in the Organic Synthesis Department of Bayer’s Central Research Division in Leverkusen, Germany. She later transitioned into the Corporate R&D Planning Department for the Bayer Board of Management, and was promoted to Manager in the Strategic Planning Department, where she focused on global merger & acquisition strategies and transactions. Joanne subsequently transferred to Bayer Corporation in West Haven, Connecticut where she was a Senior Manager in Bayer Healthcare’s North America Business Development & Licensing group.
Joanne earned a BA in Chemistry and French from Amherst College and a PhD in Chemistry from Massachusetts Institute of Technology. She was a NIH/NCI Postdoctoral Fellow at The Scripps Research Institute. Joanne is a member of The American Society of Clinical Oncology, The American Chemical Society, and The Licensing Executives Society.